Related references
Note: Only part of the references are listed.Mechanisms and regulation of cholesterol homeostasis
Jie Luo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Liver X Receptor Agonism Sensitizes a Subset of Hepatocellular Carcinoma to Sorafenib by Dual-Inhibiting MET and EGFR
Weiqing Shao et al.
NEOPLASIA (2020)
Metabolite sensing and signaling in cancer
Yi-Ping Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance
Xing Huang et al.
AUTOPHAGY (2019)
Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer
Jinrui Zhang et al.
CELL COMMUNICATION AND SIGNALING (2019)
Cholesterol Induces Epithelial-to-Mesenchymal Transition of Prostate Cancer Cells by Suppressing Degradation of EGFR through APMAP
Siyuan Jiang et al.
CANCER RESEARCH (2019)
MET in glioma: signaling pathways and targeted therapies
Fangling Cheng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer
Nan Jin et al.
NATURE COMMUNICATIONS (2019)
A Diversity of Selective Autophagy Receptors Determines the Specificity of the Autophagy Pathway
Vladimir Kirkin et al.
MOLECULAR CELL (2019)
Biological Functions of Autophagy Genes: A Disease Perspective
Beth Levine et al.
CELL (2019)
LC3C-Mediated Autophagy Selectively Regulates the Met RTK and HGF-Stimulated Migration and Invasion
Emily S. Bell et al.
CELL REPORTS (2019)
High cholesterol in lipid rafts reduces the sensitivity to EGFR-TKI therapy in non-small cell lung cancer
Qiufang Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges
Ramesh Butti et al.
MOLECULAR CANCER (2018)
Cargo recognition and degradation by selective autophagy
Damian Gatica et al.
NATURE CELL BIOLOGY (2018)
Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers
Alexis B. Cortot et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
CHOLESTEROL SENSING Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex
Brian M. Castellano et al.
SCIENCE (2017)
Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers
Alexis B. Cortot et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Understanding the Intersections between Metabolism and Cancer Biology
Matthew G. Vander Heiden et al.
CELL (2017)
Spatial and Temporal Regulation of Receptor Tyrosine Kinase Activation and Intracellular Signal Transduction
John J. M. Bergeron et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 85 (2016)
Coordinate regulation of autophagy and the ubiquitin proteasome system by MTOR
Jinghui Zhao et al.
AUTOPHAGY (2016)
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky et al.
AUTOPHAGY (2016)
GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis
Qing-Hai Ye et al.
CANCER CELL (2016)
MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
Mark M. Awad et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions
Claudio Vernieri et al.
CANCER DISCOVERY (2016)
Autophagy and SQSTM1 on the RHOA(d) again Emerging roles of autophagy in the degradation of signaling proteins
Amine Belaid et al.
AUTOPHAGY (2014)
EGF receptor trafficking: consequences for signaling and cancer
Alejandra Tomas et al.
TRENDS IN CELL BIOLOGY (2014)
The LIR motif - crucial for selective autophagy
Asa Birna Birgisdottir et al.
JOURNAL OF CELL SCIENCE (2013)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Spatial regulation of receptor tyrosine kinases in development and cancer
Jessica B. Casaletto et al.
NATURE REVIEWS CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma
Yilei Mao et al.
GUT (2010)
Golgi Phosphoprotein 2 (GOLPH2) Expression in Liver Tumors and Its Value as a Serum Marker in Hepatocellular Carcinomas
Marc-Oliver Riener et al.
HEPATOLOGY (2009)
Share Paper
